Companies: 10,795·Total market cap: $144.5T
Pharma Mar, S.A.

Pharma Mar, S.A.

PHMMFOTCHealthcare● Active
$106.48
+$0.00(+0.00%)
Market Cap$1.8B
P/E Ratio
52W High$110.4
52W Low$80.91

Pharma Mar, S.A.(PHMMF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PHMMF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.22B$0.17B$0.16B$0.20B$0.23B
Cost of Revenue$0.01B$0.01B$0.01B$0.01B$0.02B
Gross Profit$0.21B$0.17B$0.15B$0.18B$0.21B
Gross Margin %(computed)94.46%95.32%93.92%93.05%92.85%
Operating Expenses
R&D Expenses$0.10B$0.10B$0.10B$0.08B$0.07B
G&A Expenses$0.00B($0.00B)$0.02B$0.02B$0.02B
Total Operating Expenses$0.17B$0.16B$0.15B$0.14B$0.12B
Operating Income$0.04B$0.01B($0.00B)$0.04B$0.09B
Operating Margin %(computed)18.19%3.70%-2.42%22.45%40.22%
Interest Income$0.00B$0.01B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax$0.06B$0.01B($0.00B)$0.04B$0.10B
Income Tax Expense($0.02B)($0.01B)($0.00B)($0.01B)$0.00B
Net Income$0.07B$0.03B$0.00B$0.05B$0.09B
Net Margin %(computed)33.87%14.94%0.72%25.14%40.40%
Per Share & EBITDA
EPS (Basic)$4.36$1.49$0.06$2.73$5.14
Wtd Avg Shares0.02B0.02B0.02B0.02B0.02B
EBITDA$0.05B$0.02B$0.00B$0.05B$0.10B
EBITDA Margin %(computed)21.81%12.14%2.88%26.52%45.29%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · EUR · B

深入了解Pharma Mar, S.A.

关于Pharma Mar, S.A.(PHMMF)损益表

Pharma Mar, S.A.(PHMMF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,PHMMF实现营收$0.22B,毛利润$0.21B(毛利率94.46%),净利润$0.07B(净利率33.87%)。

常见问题

PHMMF · 4 问

Pharma Mar, S.A.(PHMMF)2025财年营收为$0.22B,同比up26.6%。

PHMMF revenuePHMMF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09